Get the Stockscreener App
1.38
0.00%
0.00
Pre-market:
1.39
0.01
+0.72%
Cibus Inc stock is traded at $1.38, with a volume of 285.42K.
It is up +0.00% in the last 24 hours and down -7.38% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.38
Open:
$1.39
24h Volume:
285.42K
Relative Volume:
0.50
Market Cap:
$105.34M
Revenue:
$3.64M
Net Income/Loss:
$-132.20M
P/E Ratio:
-0.463
EPS:
-2.9806
Net Cash Flow:
$-51.17M
1W Performance:
+5.34%
1M Performance:
-7.38%
6M Performance:
+9.52%
1Y Performance:
-50.18%
1-Day Range:
$1.3401
$1.47
1-Week Range:
$1.21
$1.47
52-Week Range:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.38 | 105.34M | 3.64M | -132.20M | -51.17M | -2.9806 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
[EFFECT] Cibus, Inc. SEC Filing - Stock Titan
Cibus Q1 earnings call highlights - MSN
Cibus (CBUS) registers 10.74M shares issuable on warrants — issuer to receive proceeds - Stock Titan
Cibus (NASDAQ: CBUS) files at‑the‑market $50M shelf with Jefferies - Stock Titan
CBUS SEC FilingsCIBUS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Cibus, Inc. (NASDAQ:CBUS) Q1 2026 Earnings Call Transcript - Insider Monkey
Cibus Earnings Call: Cash Extended, Execution Critical - TipRanks
CBUS Technical Analysis | Trend, Signals & Chart Patterns | CIBUS INC (NASDAQ:CBUS) - ChartMill
MSN Money - MSN
Number of shareholders of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus (CBUS) Q1 2026 Earnings: EPS -$0.33, Revenue $1.681M -- Bo - GuruFocus
Cibus Inc to offer securities with aggregate initial offering price up to $200 millionSEC filing - marketscreener.com
Cibus IncTo Offer Securities With Aggregate Initial Offering Price Up To $200 MillionSEC Filing - TradingView
Cibus (CBUS) registers $200M shelf and $50M ATM via Jefferies - Stock Titan
Q1 2026 Cibus Inc Earnings Call Transcript - GuruFocus
Cibus, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc.Class A Common Stock (NQ: CBUS - FinancialContent
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript Summary - Moomoo
Cibus outlines runway into late Q1 2027 while shifting US rice launch to 2029 - MSN
Cibus (CBUS) reports Q1 loss, beats revenue estimates - MSN
Earnings call transcript: Cibus Q1 2026 reveals improved cost efficiency - Investing.com UK
Cibus Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Cibus Q1 2026 reveals improved cost efficiency By Investing.com - Investing.com Nigeria
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CBUS: Commercial momentum, cost discipline, and regulatory wins drive progress toward 2027 launches - TradingView
Cibus Q1 2026 Earnings Call: Complete Transcript - Benzinga
Cibus (NASDAQ:CBUS) Edges Past Q1 Estimates as Cost Cutting Narrows Loss, Stock Jumps After-Hours - ChartMill
Cibus Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Cibus (CBUS) trims Q1 2026 loss but warns on going concern risk - Stock Titan
Cibus: Q1 Earnings Snapshot - marketscreener.com
Cibus (CBUS) Q1 2026 Earnings Transcript - The Globe and Mail
Cibus (CBUS) narrows Q1 2026 loss as cash rises to $30.3M - Stock Titan
Press Release: Cibus Reports First Quarter Financial Results and Provides Business Update - Moomoo
CBUS: Commercial execution advances with cost discipline and capital raise, supporting 2027 LATAM rice launch - TradingView
Cibus Inc expected to post a loss of 33 cents a shareEarnings Preview - TradingView
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
FMR LLC Stakes 15.0% in Cibus Inc. (NYSE: CBUS) via Schedule 13G/A - Stock Titan
Cibus Transfers Gene-Edited Herbicide-Tolerance Traits in Rice to Interoc Ahead of Latin American Launch - iGrow News
Cibus transfers gene-edited rice materials to partner Interoc By Investing.com - Investing.com Australia
Cibus (CBUS) Advances Herbicide Tolerance Testing with Interoc - GuruFocus
Cibus transfers gene-edited rice materials to partner Interoc - Investing.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):